July 27, 2017 5:08 AM ET

Life Sciences Tools and Services

Company Overview of Yumanity Therapeutics Inc.

Executive Profile

N. Anthony Coles M.D., M.P.H.

Chairman and Chief Executive Officer, Yumanity Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 12 different industries.

See Board Relationships
57--

Background

Dr. N. Anthony Coles, also known as Tony, M.D., M.P.H., serves as the Chairman and Chief Executive Officer of TRATE Enterprises, LLC. Dr. Coles serves as the Chief Executive Officer of Yumanity Therapeutics Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles served as Senior Vice President of Commercial Operations-Pharmaceutical Products of Vertex Pharmaceuticals Incorporated from March 2002 to November 1, 2005 and also served as its Head of Global Corporate and ...

Corporate Headquarters

790 Memorial Drive
Cambridge, Massachusetts 02139

United States

Phone: 617-409-5300
Fax: --

Board Members Memberships

Director
Director
Trustee
Chairman and Chief Executive Officer
2008-Present
Chairman
2014-Present
Director
2014-Present
Independent Director
2015-Present
Chairman of the Board
2017-Present
Director

Education

Master's Degree
Harvard University
MD
Duke University
BS
Johns Hopkins University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Yumanity Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.